1. Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial. Issue 5 (May 2022) Authors: Andreas, Stefan; Testa, Marco; Boyer, Laurent; Brusselle, Guy; Janssens, Wim; Kerwin, Edward; Papi, Alberto; Pek, Bonavuth; Puente-Maestu, Luis; Saralaya, Dinesh; Watz, Henrik; Wilkinson, Tom M A; Casula, Daniela; Di Maro, Gennaro; Lattanzi, Maria; Moraschini, Luca; Schoonbroodt, Sonia; Tasciotti... Journal: Lancet Issue: Volume 10:Issue 5(2022) Page Start: 435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗